AgEagle Aerial Systems Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. FINANCIAL STATEMENTS:
CONDENSED CONSOLIDATED BALANCE SHEETS
| As of | ||
|---|---|---|
| June 30, 2024 (unaudited) | December 31, 2023 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash | $977,208 | $819,024 |
| Accounts receivable, net | 1,538,941 | 2,057,546 |
| Inventories, net | 6,382,209 | 6,936,980 |
| Prepaid and other current assets | 452,762 | 548,561 |
| Note receivable | — | 185,000 |
| Total current assets | 9,351,120 | 10,547,111 |
| Property and equipment, net | 597,382 | 799,892 |
| Right-of-use assets | 2,916,300 | 3,525,406 |
| Intangible assets, net | 2,312,333 | 2,615,281 |
| Goodwill | 7,402,644 | 7,402,644 |
| Other assets | 251,057 | 265,567 |
| Total assets | $22,830,836 | $25,155,901 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Accounts payable | $3,145,128 | $3,062,794 |
| Accrued liabilities | 1,663,941 | 1,944,352 |
| Convertible note | 4,264,541 | 4,504,500 |
| Other short-term loan | 1,122,000 | — |
| Contract liabilities | 779,993 | 226,316 |
| Current portion of lease liabilities | 892,172 | 901,925 |
| Current portion of COVID loan | 293,158 | 391,545 |
| Total current liabilities | 12,160,933 | 11,031,432 |
| Long-term portion of lease liabilities | 2,119,690 | 2,721,743 |
| Long-term portion of COVID loan | 321,014 | 489,037 |
| Defined benefit plan obligation | 154,725 | 216,133 |
| Total liabilities | 14,756,362 | 14,458,345 |
| COMMITMENTS AND CONTINGENCIES (NOTE 10) | - | - |
| STOCKHOLDERS’ EQUITY: | ||
| Preferred Stock, $0.001 par value, 25,000,000 shares authorized: | ||
| Preferred Stock, Series F Convertible, $0.001 par value, 35,000 shares authorized, 4,295 shares issued and outstanding as of June 30, 2024, and 6,075 shares issued and outstanding as of December 31, 2023 | 4 | 6 |
| Common Stock, $0.001 par value, 250,000,000 shares authorized, 13,838,705 and 7,026,297 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively | 13,840 | 7,026 |
| Additional paid-in capital | 188,192,663 | 176,167,312 |
| Accumulated deficit | (180,085,841) | (165,583,091) |
| Accumulated other comprehensive (loss) income | (46,192) | 106,303 |
| Total stockholders’ equity | 8,074,474 | 10,697,556 |
| Total liabilities and stockholders’ equity | $22,830,836 | $25,155,901 |
See accompanying notes to these condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues | $3,392,538 | $3,278,212 | $7,286,985 | $7,335,281 |
| Cost of sales | 1,837,963 | 2,246,678 | 3,777,988 | 4,325,115 |
| Gross Profit | 1,554,575 | 1,031,534 | 3,508,997 | 3,010,166 |
| Operating expenses: | ||||
| General and administrative | 2,359,105 | 3,498,761 | 5,041,763 | 7,078,283 |
| Research and development | 1,082,007 | 1,369,479 | 2,212,236 | 2,951,822 |
| Sales and marketing | 653,931 | 955,845 | 1,189,354 | 1,933,720 |
| Lease impairment charge | — | 79,287 | — | 79,287 |
| Total operating expenses | 4,095,043 | 5,903,372 | 8,443,353 | 12,043,112 |
| Loss from operations | (2,540,468) | (4,871,838) | (4,934,356) | (9,032,946) |
| Other income (expense): | ||||
| Interest expense, net | (349,107) | (289,604) | (4,134,451) | (595,101) |
| Loss on disposal of fixed assets | — | — | (13,988) | — |
| Other income (expense), net | (40,133) | (129,141) | (162,500) | (262,035) |
| Total other expense, net | (389,240) | (418,745) | (4,310,939) | (857,136) |
| Net loss before provision for income taxes | (2,929,708) | (5,290,583) | (9,245,295) | (9,890,082) |
| Provision for income taxes | — | — | — | — |
| Net loss attributable to common stockholders | $(2,929,708) | $(5,290,583) | $(9,245,295) | $(9,890,082) |
| Net loss per common share - basic and diluted | $(0.24) | $(1.10) | $(0.90) | $(2.13) |
| Weighted average number of shares outstanding during the period – Basic and Diluted | 12,386,396 | 4,810,897 | 10,289,418 | 4,646,127 |
| Comprehensive income (loss): | ||||
| Net loss attributable to common stockholders | $(2,929,708) | $(5,290,583) | $(9,245,295) | $(9,890,082) |
| Amortization of unrecognized periodic pension costs | — | 699 | — | 44,044 |
| Foreign currency cumulative translation adjustment | 11,158 | 72,525 | (152,495) | 123,784 |
| Total comprehensive loss, net of tax | (2,918,550) | (5,217,359) | (9,397,790) | (9,722,254) |
| Accrued dividends on Series F Preferred Stock | (49,748) | (54,234) | (110,983) | (121,156) |
| Deemed dividends on Series F Preferred Stock | (7,751) | (4,654,918) | (5,257,455) | (4,910,894) |
| Total comprehensive loss available to common stockholder | $(2,976,049) | $(9,926,511) | $(14,766,228) | $(14,754,304) |
See accompanying notes to these condensed consolidated financial statements.
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2024
| Par $0.001 Preferred Stock, Series F Convertible Shares | Preferred Stock, Series F Convertible Amount | Par $0.001 Common Stock | Common Stock Amount | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders’ Equity | |
|---|---|---|---|---|---|---|---|---|
| Balance as of March 31, 2024 | 3,945 | $4 | 10,891,427 | $10,892 | $186,247,756 | $(57,350) | $(177,148,382) | $9,052,920 |
| Issuance of Preferred Stock, Series F Convertible, net of issuance cost | 2,100 | 2 | — | — | 2,074,998 | — | — | 2,075,000 |
| Conversion of Preferred Stock, Series F Convertible shares to Common Stock | (1,750) | (2) | 2,916,667 | 2,917 | (2,915) | — | — | — |
| Dividends on Series F Preferred Stock | — | — | — | — | (49,748) | — | — | (49,748) |
| Stock-based compensation expense | — | — | — | — | 28,535 | — | — | 28,535 |
| Issuance of Restricted Common Stock | — | — | 30,611 | 31 | (31) | — | — | — |
| Deemed dividend on Series F Preferred Stock | — | — | — | — | 7,751 | — | (7,751) | — |
| Issuance costs for sale of Preferred Stock | — | — | — | — | (113,683) | — | — | (113,683) |
| Foreign currency cumulative translation adjustment | — | — | — | — | — | 11,158 | — | 11,158 |
| Net loss | — | — | — | — | — | — | (2,929,708) | (2,929,708) |
| Balance as of June 30, 2024 | 4,295 | $4 | 13,838,705 | $13,840 | $188,192,663 | $(46,192) | $(180,085,841) | $8,074,474 |
| Par $0.001 Preferred Stock, Series F Convertible Shares | Preferred Stock, Series F Convertible Amount | Par $0.001 Common Stock | Common Stock Amount | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders’ Equity | |
|---|---|---|---|---|---|---|---|---|
| Balance as of December 31, 2023 | 6,075 | $6 | 140,520,163 | $140,521 | $176,033,817 | $106,303 | $(165,583,091) | $10,697,556 |
| Effect on existing shares due to Reverse Split on February 9, 2024 | — | — | (133,493,864) | (133,495) | 133,495 | — | — | — |
| Issuance of Preferred Stock, Series F Convertible, net of issuance cost | 3,100 | 3 | — | — | 3,024,997 | — | — | 3,025,000 |
| Conversion of Preferred Stock, Series F Convertible shares to Common Stock | (4,880) | (5) | 5,868,717 | 5,869 | (5,864) | — | — | — |
| Conversion of Convertible Note principal to Common Stock | — | — | 79,828 | 80 | 99,920 | — | — | 100,000 |
| Dividends on Series F Preferred Stock | — | — | — | — | (110,983) | — | — | (110,983) |
| Exercise of warrants issued with Series F | — | — | 829,500 | 830 | 496,871 | — | — | 497,701 |
| Stock-based compensation expense | — | — | — | — | 47,115 | — | — | 47,115 |
| Issuance of Restricted Common Stock | — | — | 34,361 | 35 | (35) | — | — | — |
| Conversion Price of Promissory Note on Exchange Agreement | — | — | — | — | 3,488,851 | — | — | 3,488,851 |
| Deemed dividend on Series F Preferred Stock | — | — | — | — | 5,257,455 | — | (5,257,455) | — |
| Issuance costs for sale of Preferred Stock | — | — | — | — | (272,976) | — | — | (272,976) |
| Foreign currency cumulative translation adjustment | — | — | — | — | — | (152,495) | — | (152,495) |
| Net loss | — | — | — | — | — | — | (9,245,295) | (9,245,295) |
| Balance as of June 30, 2024 | 4,295 | $4 | 13,838,705 | $13,840 | $188,192,663 | $(46,192) | $(180,085,841) | $8,074,474 |
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023
| Par $0.001 Preferred Stock, Series F Convertible Shares | Preferred Stock, Series F Convertible Amount | Par $0.001 Common Stock | Common Stock Amount | Additional Paid-In Capital | Accumulated Other Comprehensive Income | Accumulated Deficit | Total Stockholders’ Equity | |
|---|---|---|---|---|---|---|---|---|
| Balance as of March 31, 2023 | 7,865 | $8 | 90,771,375 | $90,772 | $158,378,640 | $104,687 | $(116,408,919) | $42,165,188 |
| Effect on existing shares due to Reverse Split on February 9, 2024 | — | — | (86,232,806) | (86,233) | 86,233 | — | — | — |
| Sales of common stock, net of issuance costs | — | — | 836,000 | 836 | 3,816,564 | — | — | 3,817,400 |
| Conversion of Preferred Stock, Series F Convertible shares to Common Stock | (840) | (1) | 100,000 | 100 | (99) | — | — | — |
| Dividends on Series F Preferred Stock | — | — | — | — | (54,234) | — | — | (54,234) |
| Deemed dividend on Series F Preferred Stock and warrant | — | — | — | — | 4,654,918 | — | (4,654,918) | — |
| Stock-based compensation expense | — | — | — | — | 469,835 | — | — | 469,835 |
| Amortization of unrecognized periodic pension costs | — | — | — | — | — | 699 | — | 699 |
| Foreign currency cumulative translation adjustment | — | — | — | — | — | 72,525 | — | 72,525 |
| Net loss | — | — | — | — | — | — | (5,290,583) | (5,290,583) |
| Balance as of June 30, 2023 | 7,025 | $7 | 5,474,569 | $5,475 | $167,351,857 | $177,911 | $(126,354,420) | $41,180,830 |
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023
| Par $0.001 Preferred Stock, Series F Convertible Shares | Preferred Stock, Series F Convertible Amount | Par $0.001 Common Stock Shares | Common Stock Amount | Additional Paid-In Capital | Accumulated Other Comprehensive Income | Accumulated Deficit | Total Stockholders’ Equity | |
|---|---|---|---|---|---|---|---|---|
| Balance as of December 31, 2022 | 5,863 | $6 | 88,466,613 | $88,467 | $154,679,363 | $10,083 | $(111,553,444) | $43,224,475 |
| Effect on existing shares due to Reverse Split on February 9, 2024 | — | — | (84,043,282) | (84,043) | 84,043 | — | — | — |
| Sales of common stock, net of issuance costs | — | — | 836,000 | 836 | 3,816,564 | — | — | 3,817,400 |
| Issuance of Preferred Stock, Series F Convertible, net of issuance cost | 3,000 | 3 | — | — | 2,999,997 | — | — | 3,000,000 |
| Conversion of Preferred Stock, Series F Convertible shares to Common Stock | (1,838) | (2) | 215,238 | 215 | (213) | — | — | — |
| Dividends on Series F Preferred Stock | — | — | — | — | (121,156) | — | — | (121,156) |
| Deemed dividend on Series F Preferred Stock and warrant | — | — | — | — | 4,910,894 | — | (4,910,894) | — |
| Stock-based compensation expense | — | — | — | — | 982,365 | — | — | 982,365 |
| Amortization of unrecognized periodic pension costs | — | — | — | — | — | 44,044 | — | 44,044 |
| Foreign currency cumulative translation adjustment | — | — | — | — | — | 123,784 | — | 123,784 |
| Net loss | — | — | — | — | — | — | (9,890,082) | (9,890,082) |
| Balance as of June 30, 2023 | 7,025 | $7 | 5,474,569 | $5,475 | $167,351,857 | $177,911 | $(126,354,420) | $41,180,830 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.